Calvin Vu

Calvin Vu has extensive work experience in the biomedical field, spanning from 2001 to the present. Calvin'smost recent role is as a Scientist at Santa Ana Bio, Inc since June 2021. Prior to that, they worked as an Associate Scientist at CERo Therapeutics from May 2020 to June 2021. From June 2019 to May 2020, they held the position of Associate Scientist at Kite Pharma, where they later became the Sr. Research Associate II/Vivarium Manager from August 2017 to June 2019. Prior to Kite Pharma, they worked as an Associate Scientist (Contract) at Celgene from February 2014 to August 2017, and as a Sr. Research Associate (Contract) at Halozyme Therapeutics, Inc. from May 2013 to February 2014. Calvin also has experience as a Senior Research Associate Scientist at CovX (a Pfizer company) from 2009 to April 2013, a Research Associate II at Amylin Pharmaceuticals from 2005 to 2009, and a Research Associate I at X-Ceptor from 2001 to 2005, where they were responsible for various tasks related to pharmacokinetic studies, genomic DNA preparation, genotyping, animal husbandry, and maintenance of an animal colony.

From 1996 to 2000, Calvin Vu attended California State University San Marcos. Although no degree or field of study was specified, this indicates that Calvin had some level of education at this institution during this time period.